Skip to content

Q2 2023 strategic insights 💡

The 6-month rally in equity markets is likely to lose momentum or even reverse if recessionary risks materialise later in 2023. Corporate earnings are likely to remain under pressure in an environment still hampered by low growth and persistent inflation. Lifted by a six month rally, current valuation s are not very attractive and do not fully reflect recession and financial instability risks. A defensive bias remains appropriate.

Macro

The ECB enters uncharted territory

Compulsive and continuous interest rate hikes could give way to a long period of inaction.

Read More →
Macro

The focus is shifting to Frankfurt

Despite persisting inflation, weaker economic conditions should prompt the ECB to adopt a cautious stance.

Read More →
Macro

Neither too hot nor too cold (for now)

Recent mixed indicators are still compatible with a “soft landing” for the US economy.

Read More →
Macro

Powell preaches careful austerity

Western central bankers seem prepared to sacrifice more growth to restore price stability.

Read More →
Macro

Bears make a comeback in August

The continued strength of the U.S. economy is fueling a sustained “bear steepening” of the dollar yield curve.

Read More →
Macro

Risks of a US recession are receding (a little)

The rebound in long-term yields is hampering the exuberant rally in equities, but it bodes well for the future.

Read More →
Macro

Long-term bonds take a beating

Fitch’s surprise decision to cut US credit rating and robust indicators trigger bond market correction.

Read More →
Macro

Summer torpor takes hold of the markets

Sessions come and go, but a sideways trend has prevailed since the beginning of July.

Read More →
Corporate

H1 2023 Financial Results

Following the successful completion of our turnaround last year, we’re pleased to share our latest financial achievements with you today.

Read More →
Macro

“Time to stop tightening”, warns Mr. Market

Impatient central banks are exposing themselves to the increasingly obvious risk of overdose.

Read More →